Innospec REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS

(NASDAQ: IOSP) Innospec Inc. announced its financial results for the third quarter ended September 30, 2026, and declared a semi-annual dividend of 94 cents per common share for the second half of 2026, payable on November 25, 2026 to shareholders of record as of November 17, 2026. The annual dividend is now $1.86 per share, representing a 9 percent increase over 2025. Total revenues for the third quarter were $473.6 million, up 7 percent from $441.9 million in the same period last year. Net income attributable to Innospec for the quarter was $31.8 million, or $1.29 per diluted share, compared to $12.9 million, or $0.52 per diluted share, last year. Adjusted EBITDA for the quarter was $51.4 million, compared to $44.2 million a year ago. Cash from operating activities was $17.4 million before capital expenditures of $15.6 million in the quarter. The company ended the quarter with net cash of $251.9 million and no debt. Adjusted non-GAAP EPS in the third quarter was $1.29 per diluted share, compared to $1.12 per diluted share a year ago. Performance Chemicals revenues were $180.5 million, up 6 percent from $170.8 million last year, with operating income of $16.9 million, an 84 percent increase from $9.2 million. Fuel Specialties revenues were $180.7 million, up 5 percent from $172.0 million, with operating income of $35.6 million, up 1 percent from $35.3 million. Oilfield Services revenues were $112.4 million, up 13 percent from $99.1 million, with operating income of $6.7 million, up 40 percent from $4.8 million. Corporate costs for the quarter were $18.6 million, compared to $18.2 million a year ago. The adjusted effective tax rate for the quarter was 24.7 percent, compared to 22.7 percent last year. For the quarter, cash provided by operating activities was $17.4 million, compared to $39.1 million a year ago. As of September 30, 2026, Innospec had $251.9 million in cash and cash equivalents. Net sales for the nine months ended September 30, 2026 were $1,418.2 million, compared to $1,322.4 million for the same period in 2025. Net income attributable to Innospec for the nine months was $93.0 million, compared to $69.2 million last year. Adjusted EBITDA for the nine months was $145.2 million, compared to $147.3 million last year. Segmental net sales for the nine months were: Performance Chemicals $540.2 million, Fuel Specialties $548.0 million, and Oilfield Services $330.0 million. Operating income for the nine months was: Performance Chemicals $44.0 million, Fuel Specialties $109.7 million, Oilfield Services $21.0 million, and corporate costs of $62.5 million. The company highlighted strong operating income growth and margin improvement, particularly in Performance Chemicals and Oilfield Services, and noted significant balance sheet flexibility for organic investment, M&A, dividend growth, and buybacks.